Varian Medical Systems (NYSE:VAR) updated its FY18 earnings guidance on Friday. The company provided earnings per share guidance of ~$4.05-4.17 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.30. The company issued revenue guidance of +3-5% to ~$2.78-2.8 billion, compared to the consensus revenue estimate of $2.76 billion.

Varian Medical Systems (VAR) opened at $111.53 on Friday. Varian Medical Systems has a 52 week low of $76.94 and a 52 week high of $114.09. The stock has a market cap of $10,220.00, a P/E ratio of 40.41, a price-to-earnings-growth ratio of 3.26 and a beta of 0.68.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company had revenue of $739.00 million for the quarter, compared to analyst estimates of $741.69 million. During the same quarter in the previous year, the company posted $1.03 EPS. The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. research analysts forecast that Varian Medical Systems will post 4.25 earnings per share for the current year.

Several equities analysts have issued reports on VAR shares. Zacks Investment Research downgraded shares of Varian Medical Systems from a hold rating to a sell rating in a report on Friday, October 27th. Citigroup increased their price objective on shares of Varian Medical Systems from $119.00 to $121.00 and gave the company a neutral rating in a report on Monday, October 30th. Royal Bank of Canada set a $105.00 price objective on shares of Varian Medical Systems and gave the company a hold rating in a report on Thursday, November 30th. BTIG Research reaffirmed a hold rating on shares of Varian Medical Systems in a report on Sunday, October 29th. Finally, Evercore ISI began coverage on shares of Varian Medical Systems in a research report on Wednesday, January 3rd. They issued an underperform rating and a $100.00 target price for the company. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus price target of $100.44.

In other Varian Medical Systems news, SVP John W. Kuo sold 7,991 shares of the business’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $110.65, for a total value of $884,204.15. Following the transaction, the senior vice president now directly owns 27,363 shares of the company’s stock, valued at approximately $3,027,715.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Kolleen T. Kennedy sold 931 shares of the business’s stock in a transaction on Wednesday, October 18th. The shares were sold at an average price of $105.00, for a total transaction of $97,755.00. Following the completion of the transaction, the executive vice president now directly owns 27,531 shares in the company, valued at $2,890,755. The disclosure for this sale can be found here. Insiders sold 111,727 shares of company stock valued at $12,392,515 in the last quarter. 0.78% of the stock is owned by insiders.

COPYRIGHT VIOLATION WARNING: “Varian Medical Systems (VAR) Releases FY18 Earnings Guidance” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2018/01/12/varian-medical-systems-var-releases-fy18-earnings-guidance.html.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Earnings History and Estimates for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.